Skip to content
Menu

Bausch Health Companies Inc. BHC.TO

Full chart Compare
Set alert

Price alert · BHC.TO

All alert types
12.52 CAD 0.00 (+0.00%)

As ofNov 19, 2026, 1:37 PM EST

12.32 Day range 12.65
6.10 52-week range 12.66
YTD
+31.37%
1 year
+47.29%

 

No chart data for this range yet.
Market cap
4.69B
Revenue (ttm)
11.11B
Profit margin
-7.57%
EPS (ttm)
-3.14
Shares out
374.27M
Forward P/E
2.05
YTD return
+31.37%
1-year return
+47.29%
Volume
228.82K
Avg volume
656.49K
Open
12.42
Previous close
12.52
Day's range
12.32 – 12.65
52-week range
6.10 – 12.66
Beta
0.28
50-day average
9.39

Key statistics

200-day average
8.09
Enterprise value
23.75B
PEG ratio
0.02
Price / sales
0.42
Revenue growth
9.70%
Free cash flow
1.64B
Total cash
2.48B
Total debt
20.71B
Return on equity
-11040.00%
Short % of float
1.46%

About Bausch Health Companies Inc.

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, Czech Republic, Slovakia, Ukraine, Bulgaria, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on BHC.TO — it syncs with the Stock Master app.

Insider holders

BHC.TO insider holders
InsiderRelationLatest transactionDateShares held
APPIO THOMAS JChief Executive OfficerStock Award(Grant)Feb 24, 20263,620,030
CARSON SEANA LYNNEGeneral CounselSaleMar 2, 2026616,761
CHARHON JEAN-JACQUESChief Financial OfficerStock Award(Grant)Feb 24, 2026755,538
KAVANAGH SARAH BALDWINDirectorStock Award(Grant)May 21, 2026282,230
LENAR AIMEE JOfficerSaleAug 18, 2026334,853
MILLER STEVEN DDirectorStock Award(Grant)May 15, 2025239,224

Institution ownership

BHC.TO institution ownership
Holder% heldSharesValueReported
PAULSON & CO. INC.19.57%73,255,869917.16MSep 29, 2026
Goldentree Asset Management LP9.26%34,665,731434.01MSep 29, 2026
Royal Bank of Canada2.45%9,187,080115.02MSep 29, 2026
Goldman Sachs Group Inc2.07%7,748,37897.01MSep 29, 2026
Vanguard Capital Management LLC1.99%7,444,58993.21MSep 29, 2026
Two Sigma Investments, LP1.98%7,410,21592.78MSep 29, 2026

Fund ownership

BHC.TO fund ownership
Holder% heldSharesValueReported
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund1.00%3,762,19247.10MJul 30, 2026
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund0.66%2,481,31331.07MJun 29, 2026
SCHWAB STRATEGIC TRUST-Schwab Fundamental International Equity ETF0.43%1,617,41220.25MAug 30, 2026
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap 0.26%986,06612.35MJul 30, 2026
DFA INVESTMENT TRUST CO-The Canadian Small Company Series0.22%815,01010.20MJul 30, 2026
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.0.16%594,5117.44MJul 30, 2026